Therapeutic options in COVID-19
E Horwitz, O Perzon, D Mevorach - Autoimmunity, COVID-19, Post …, 2023 - Elsevier
Abstract Treatment of COVID-19 can be categorized into prophylactic treatment, early-stage
treatment, and late-stage treatment. Prophylactic treatment, as either pre or postexposure …
treatment, and late-stage treatment. Prophylactic treatment, as either pre or postexposure …
COVID-19: immunology, immunopathogenesis and potential therapies
Abstract The Coronavirus Disease-2019 (COVID-19) imposed public health emergency and
affected millions of people around the globe. As of January 2021, 100 million confirmed …
affected millions of people around the globe. As of January 2021, 100 million confirmed …
A hitchhiker's guide through the COVID-19 galaxy
S Felsenstein, AO Reiff - Clinical Immunology, 2021 - Elsevier
Numerous reviews have summarized the epidemiology, pathophysiology and the various
therapeutic aspects of Coronavirus disease 2019 (COVID-19), but a practical guide on “how …
therapeutic aspects of Coronavirus disease 2019 (COVID-19), but a practical guide on “how …
[PDF][PDF] The COVID-19 Summary: Immunological Facts and Figures
L Das, D Dasgupta - books.lucp.net
The recent Coronavirus disease (COVID-19) has disrupted health as well as economic
status throughout the globe. In December 2019, a sudden outbreak of pneumonia …
status throughout the globe. In December 2019, a sudden outbreak of pneumonia …
[PDF][PDF] COVID-19: Immune Perspective and Current Treatment Strategies
Abstract Coronavirus disease 2019 (COVID-19) is now a well-established and a lethal
respiratory pandemic, affecting millions with about 10% fatality rate. Infected patients show …
respiratory pandemic, affecting millions with about 10% fatality rate. Infected patients show …
[HTML][HTML] COVID-19: Immunology & Therapeutics
M Chowdhury, S Pant, N Mahishi, M Soneja, N Wig - meditropics.com
The World Health Organization (WHO) declared COVID-19 as a pandemic on March 11,
2020, after it was declared a public health emergency on January 30, 2020. The disease …
2020, after it was declared a public health emergency on January 30, 2020. The disease …
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments
P Goodarzi, F Mahdavi, R Mirzaei, H Hasanvand… - International …, 2020 - Elsevier
The SARS-CoV-2 virus is an etiological agent of pandemic COVID-19, which spreads
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
rapidly worldwide. No proven effective therapies currently exist for this virus, and efforts to …
[HTML][HTML] SARS-CoV-2: immune response elicited by infection and development of vaccines and treatments
G Canedo-Marroquin, F Saavedra… - Frontiers in …, 2020 - frontiersin.org
The World Health Organization (WHO) announced in March a pandemic caused by Severe
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2). This new infectious disease was …
COVID-19: Between past and present
Since the WHO declared coronavirus disease 2019 (COVID-19) as a pandemic, huge efforts
were made to understand the disease, its pathogenesis, and treatment. COVID-19 is caused …
were made to understand the disease, its pathogenesis, and treatment. COVID-19 is caused …
[HTML][HTML] COVID-19: considerations about immune suppression and biologicals at the time of SARS-CoV-2 pandemic
G Costanzo, W Cordeddu, L Chessa… - World Journal of …, 2021 - ncbi.nlm.nih.gov
The extent of the profound immunological and nonimmunological responses linked to
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently being …
severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is currently being …